TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/7/23 21:32 | 6/6/23 | PCRX | Pacira Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Slonin Jonathan | FL | O | Chief Cl | S.m | -37 | 38.42 | 0 | -1 | -3 | 36 | D | ||||||||||||||
8/5/22 16:04 | 8/3/22 | PCRX | Pacira Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Slonin Jonathan | FL | O | Chief Cl | S | -17 | 55.70 | 0 | 0 | -1 | 37 | D | ||||||||||||||
7/7/22 19:04 | 7/5/22 | PCRX | Pacira Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Slonin Jonathan | FL | O | Chief Cl | S | -53 | 57.19 | 0 | -1 | -2 | 37 | D | ||||||||||||||
6/8/22 19:45 | 6/6/22 | PCRX | Pacira Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Slonin Jonathan | FL | O | Chief Cl | S.d | -22 | 61.37 | 0 | 0 | -1 | 38 | D | ||||||||||||||
5/25/22 16:16 | 5/23/22 | PCRX | Pacira Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Slonin Jonathan | FL | O | Chief Cl | M.d | 105 | 52.37 | 0 | 2 | 8 | 29 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |